Presentation Information
[3P-738]Harnessing an integrated glyco-nanovaccine technology for enhanced cancer immunotherapy
○Mayumi Niimura1, Yasuhisa Sakamoto1, Mayuko Shimoda1, Narumi Harada1, Ayato Maeda1, Shiho Wada3, Koki Murata3, Saisai Liu1, Haruka Ohara3, Yohei Kanamori1, Akihiro Nita1, Masahiro Wakao3, Hiroyuki Shinchi3, Toshiro Moroishi1,2 (1. Faculty of Life Sciences, Kumamoto University, 2. Center for Metabolic Regulation of Healthy Aging, Kumamoto University, 3. Graduate School of Science and Engineering, Kagoshima University)
Password required to view
Log in
or
Comment
To browse or post comments, you must log in.Log in